Mochida Pharmaceutical Co.,Ltd.
4534 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 新宿区四谷一丁目７番地
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Mochida Pharmaceutical Co., Ltd. is a prominent Japanese pharmaceutical company known for its commitment to research and development in the healthcare sector. Established in the early 20th century, the company specializes in the discovery, manufacturing, and marketing of innovative pharmaceuticals, particularly in areas such as neurology, psychiatry, and infectious diseases. Mochida emphasizes the importance of quality and efficacy, striving to improve patients' quality of life through its diverse range of products. With a strong focus on sustainability and ethical practices, the company aims to contribute positively to global healthcare challenges while expanding its presence in both domestic and international markets.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-01 03:25 |
Inside Information Statement
臨時報告書
|
Japanese | 28.8 KB | |
| 2025-06-27 06:50 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2025-06-27 06:49 |
Internal Control over Financial Reporting
内部統制報告書－第87期(2024/04/01－2025/03/31)
|
Japanese | 24.7 KB | |
| 2025-06-27 06:43 |
Annual Report
有価証券報告書－第87期(2024/04/01－2025/03/31)
|
Japanese | 1.9 MB | |
| 2024-11-11 01:36 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2024-11-11 01:35 |
Interim Report
半期報告書－第87期(2024/04/01－2025/03/31)
|
Japanese | 192.6 KB | |
| 2024-06-28 06:36 |
Inside Information Statement
臨時報告書
|
Japanese | 28.0 KB | |
| 2024-06-27 07:03 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2024-06-27 07:02 |
Internal Control over Financial Reporting
内部統制報告書－第86期(2023/04/01－2024/03/31)
|
Japanese | 23.5 KB | |
| 2024-06-27 07:01 |
Annual Report
有価証券報告書－第86期(2023/04/01－2024/03/31)
|
Japanese | 1.5 MB | |
| 2024-02-13 02:30 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2024-02-13 02:29 |
Quarterly Report
四半期報告書－第86期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 161.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
MPH Health Care | Germany | 93M1 | |
|
MUROMACHI CHEMICALS INC. | Japan | 4885 | |
|
NANO MRNA Co.,Ltd. | Japan | 4571 | |
|
NATAC | Spain | NAT | |
|
Navamedic | Norway | NAVA | |
|
Newbury Pharmaceuticals AB | Sweden | NEWBRY | |
|
New Nordic Healthbrands AB | Sweden | NNH | |
|
Nicoccino Holding AB | Sweden | NICO | |
|
Nicox S.A. | France | COX | |
|
NIPPON CHEMIPHAR CO., LTD. | Japan | 4539 |